BSECompany Update2d ago · 7 Nov 2026, 03:18 pm

Newspaper Advertisement enclosed herewith.

Supriya Lifescience Ltd · 543434

✦ AI Summary▲ PositiveResults

Supriya Lifescience Ltd has published an unaudited standalone financial results for the quarter and half year ended September 30, 2026, which includes total revenue from operations of ₹2,062.97 crore, net profit of ₹377.78 crore, and earnings per share of ₹3.63.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

6c24e33b-6add-41ab-9d5e-014a273bf587.pdf

pdf

Download →
View document text
SUPRIYA LIFESCIENCE LTD. .. Creating h·ue values tltat bind global l,ealtlt November 7, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir (s), Subject: Newspaper Advertisement- Regulation 47 and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In terms of Regulation 30 read with Schedule III and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper advertisement published in Financial Express and Loksatta on Saturday, November 7, 2026, containing extract of Unaudited Financial Results for the quarter and half year ended September 30, 2026. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LIMITED Regd Off: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai -400063 Tel: + 91 22 4033 2727 ���������������������������� Email: cs@supriyalifescience.com Website: www.supriyalifescience.com Statement of Unaudited Standalone Financial Results for the Quarter and Half year ended September 30 ,2026 Millions Quarter Ended Half Ytar ended Yea, Ended 38,09-2026 30,06,2026 30,()9-2025 30,09·2026 30-09-2025 31,()3,2026 1 Total Revenue from Operations 2.062.97 1,897.47 1,998.33 3,000.44 3,449.07 8,278.75 2 Net ProfiV(Loss) for the penod 377.78 407.92 683.18 785.70 1,157.30 2,752.37 3 Net Prof.V(loss) for lhe period before Tax, 377,78 407.92 683.18 785.70 1,157.30 2,747.79 (after Exceptional items) 4 Net ProfiV(Loss)forthe period afferTax 292.50 240.43 504.27 532.93 852.17 2,091.20 ���������� (after Exceptional items) 5 Total Comprehensive income for the period other Comprehensive Income (after lax) 292.50 240.43 504.27 532·.93 852.17 2,091.20 6 Equity Share capital (Face value Rs.21-each) 160.97 160.97 160.97 160.97 160.97 160.97 8 Earning pe, share (Face Value Rs2/-each) (not annuatise 1. Sasic 3.63 2.99 6.27 6.62 10.59 25.98 a) The above Unaudited Financial Results have been rev~ed by the Audit Committee and approved by the Board of Directors at their respective meetings held on Novembef 6; 2026. The Auditors of the Company have carlled outtimited reviewofthe Unaudited Flnancial Results for the Quarte r and Half year ended September 30, 2026. b) The above is an extract of the delailed format of slatement of Slandalone Unaudited Financial Results for the Qua~er and Half Year ended September 30, 2026 filed with the $lock Exchange under Regulation 33 of 1he SE Bl (Listing and Other Disclosure Requirements) ���� Regulations, 2015. The fvll format of the Qua~er and Half Year ended September 30,2026 Financial Results are available on the website of the Company (www,supriyalifescience,coml .1he SSE Limited (www.bseindia.com), The National Stock Exchnage of India Ltd Sd/· Or. Salonl Wagh Ptaee : l,tumbaJ Managing Director Oat•: Novembo< 6, 2026 DIN: 08491◄10 PATEL KNR HEAVY INFRASTRUCTURES LIMITED CIN· U70102TG2008PLC0•9949 Rogd Office• KNR liouse, >th Floor. Plot No 114, Pt,as&-1. KaW<1 Iii!■, Hydorabad,,500033 Pl\ <91 40 4~781/62. Fae '91 40 40268760 Sustainability. Growth. Profitability. EXTRACT OF UNAUDITED STANDALONE FINANCIAL RES ULT S FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2026 I RS L."-l LAM.HS) Standalone Quarter Quarter Q~art.er HaJfYear lialf Year YeM No PARTICULARS Ended Ended Ended Ended Ended Ended 30--09-2026 30-2026 30-09-2025 30-09-2026 30-09-2025 31-03-2026 JNK INDIA LIMITED Unaudited 11 ...a udl•. . o<t Unaudited Un-audited Unaudited Audited 1. Total ,neome from operaUons 785.49 1,952.65 766.55 2.73814 1,601.61 6,219.92 2 Net Profit I (loss) for Ille period (beloreTax. (FORMERLY KNOWN AS JNK INDIA PRIVATE LIMITED) Exceotionat ltemsi 1155,321 1,631.03 42.51 1,475.71 235.02 3,297.34 R'1jls1ere<l Office : Ural No. .2 03, 20•. 205 & 206, Opp. TMC Office, Cent.rum IT Park. 3 Net ProfiV(loss) for the period (before Tax, Near Sal!<ar Hotel, Thane-W;is1, Thane -400604, Maharasl>lra CIN:l29268MH2010PLC204223. Web$11>: \WIW,jnkln(lla.com After Exceptional liems) 1155.32) 1,631.03 42.51 1,475.71 235.02 3.297.34 4 Net Prolil I (loss) ror the period (after Tax, EXTRACT OF STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS EJiceptional llems) (92.90) 1,543.99 (29 60) 1,451.09 147.95 2,831.42 ' TolBI Comprehensive Income for the penod lNRinMil!ion (Comprising Pror.t/(los,) ror the period Sr. Particulars Quarter ended Six Months Ended Year ended (anor tax) an<I Other Compriltlonslva No. 3oro September, 30'' June, 30" September, 30" September, 30" s,ptember, 31" March, 2026 2026 2025 2026 2025 2026 Income (allor taxll (92.901 1.~3.99 (29.801 1,451.09 147.95 2.831.◄2 ,_6 Paid up E_gulty Sharo C8~dal 2,382.38 2,382.38 2,382.38 2,382.38 2,c382.38 2 382.38 [Unaudited) [Unaudited} [Unaudited} (Unaudlled) (Unaudlte<l) (Audited} 7 Oebl Eqully Ratio 0.10 021 053 0.10 0.53 0.23 1 Re,e~ue from operations 1,840.29 1,799.63 1,783.79 3,639 92 2,774.78 8, f .53 8 Earnings Per Share "2 Profit before exceptional items and tax 174.48 146.35 178.12 320.83 197.93 852.15 1, Balle: ~ j__ (0.38)" 6.48· 10.12,t 8.08· 0.82' 11.88 3 Profit before laX 174.48 146.35 178.12· 320.83 197.93 852.15 2. DIiuted: (Ra I {0.301' (0.12)' 8.09· 0.82· 11.88 6◄8' 4 Net profit all<!< "" 132.77 96.25 130.23 229.02 141.50 648.20 9 Debenture RedMIJ)\lon Reoe,ve 13800 288,00 521.20 138.00 52120 288.00 5 Net profit after tax anributable lo 0"""'" or 132.13 114.67 131.88 2•6.80 143.16 6'19.49 10 Oebl Service Cove=e Ratio • 10.011 938 2.15 041 2-15 0.84 the Company 11 Interest Servfoe Coven,ge Ratio # (1.07) 22.95 I 20 1087 1.55 ◄.91 6 Total OOl1'4)rehenslv<> income atllillu1able to 138.83 108.69 135,15i 247 52 144.10 652.24 o'llners of'the Company • Not Annualized 7 Paid-up equity share capilal 111.91 II The Debi Servloe Coverage rallo and 1meresi Servlt:e Coverage ratio is below ooe due 10 IN'D-AS Impacts and early reoemption (Face value of share INR 2 each) of Oebentures. 8 Other equity at1rlbuJable lo owne,s ohhe Company 5,564.59 Notes : 1. The above is an extract ol llle derailed fDmlat of FlnanciBI ReSUlts for the Quaru,r ended september ,2026 filed wim the Slock 9 £am,ng per share (EPS) Exchange under Regulation 52 or Listing Regulations. The lull fonnat of the Quarter an<I liaH year ended September 2026 8asic EPS (Rs.) 2.36 2.36 4.41 2.56 11.61 Financial Resulls are available on Ille Stoel< E>iehange website namely. BSE Umtted (www.bseindla.com). Diluted EPS (Rs.) 2.36 2.38, 4.41 2.56 11.61 2. The above financlal resuns were reviewed and approved and taken on record by the Soard in their meeUng held on 04th (not "'".'ualised)l (n_ot annu~sed):. i..(.n.~ ot.~.=...~,.lis"e"'da)laa""('annua&sed) November 2026 EXTRACT OF STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS 3. The figures have been regrouped and/or rearranged wherever conSidered necessary. Sr, Particu1ars Quarter ended Six Months Ended Yearonded For Patel KNR l-leavy 1nlrasuucwres ltd No. 30"' September, 3d' June, 30" September, 30" September, 30" September, 31''Mareh, Sd/- 2026 2026 2025 2026 2025 2026 (RahulAgaiwal) Place : Hyderabad Director (Unaudlled) IUnaudhedJ (Unaudited) (Unaudlled) (Unaudited) (Audited) Dale : 04-11-2026 DIN • 08407819 1 Revenue [Showing first 8,000 characters — download PDF for full document]